240 related articles for article (PubMed ID: 16083874)
1. Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Ducroq J; Rouet R; Puddu PE; Sallé L; Tabourel C; Ducouret P; Gérard JL
Eur J Pharmacol; 2005 Aug; 518(2-3):165-74. PubMed ID: 16083874
[TBL] [Abstract][Full Text] [Related]
2. Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Ducroq J; Rouet R; Sallé L; Puddu PE; Repessé Y; Ghadanfar M; Ducouret P; Gérard JL
Eur J Pharmacol; 2006 Feb; 532(3):279-89. PubMed ID: 16480976
[TBL] [Abstract][Full Text] [Related]
3. I(Ks) blockade in border zone arrhythmias from guinea-pig ventricular myocardium submitted to simulated ischemia and reperfusion.
Puddu PE; Sallé L; Gérard JL; Rouet R; Ducroq J
Fundam Clin Pharmacol; 2012 Aug; 26(4):445-53. PubMed ID: 21781157
[TBL] [Abstract][Full Text] [Related]
4. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?
Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J
Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium.
Rouet R; Picard S; Libersa C; Ghadanfar M; Alabaster C; Gérard JL
Circulation; 2000 Jan 4-11; 101(1):86-93. PubMed ID: 10618309
[TBL] [Abstract][Full Text] [Related]
6. Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion.
Thomas GP; Howlett SE; Ferrier GR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1379-86. PubMed ID: 7562511
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
[TBL] [Abstract][Full Text] [Related]
8. KATP channels and 'border zone' arrhythmias: role of the repolarization dispersion between normal and ischaemic ventricular regions.
Picard S; Rouet R; Ducouret P; Puddu PE; Flais F; Criniti A; Monti F; Gérard JL
Br J Pharmacol; 1999 Aug; 127(7):1687-95. PubMed ID: 10455327
[TBL] [Abstract][Full Text] [Related]
9. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
[TBL] [Abstract][Full Text] [Related]
10. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
[TBL] [Abstract][Full Text] [Related]
11. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
[TBL] [Abstract][Full Text] [Related]
12. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide.
Bril A; Forest MC; Cheval B; Faivre JF
Cardiovasc Res; 1998 Jan; 37(1):130-40. PubMed ID: 9539867
[TBL] [Abstract][Full Text] [Related]
13. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
[TBL] [Abstract][Full Text] [Related]
14. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
Osadchii OE
Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
[TBL] [Abstract][Full Text] [Related]
15. Multiple cellular electrophysiological effects of azimilide in canine cardiac preparations.
Takács J; Iost N; Lengyel C; Virág L; Nesic M; Varró A; Papp JG
Eur J Pharmacol; 2003 Jun; 470(3):163-70. PubMed ID: 12798954
[TBL] [Abstract][Full Text] [Related]
16. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
Gintant GA
J Cardiovasc Pharmacol; 1998 Jun; 31(6):945-53. PubMed ID: 9641481
[TBL] [Abstract][Full Text] [Related]
17. Effects of azimilide on the muscarinic acetylcholine receptor-operated K+ current and experimental atrial fibrillation in guinea-pig hearts.
Nishida A; Reien Y; Ogura T; Uemura H; Tamagawa M; Yabana H; Nakaya H
J Pharmacol Sci; 2007 Nov; 105(3):229-39. PubMed ID: 17965539
[TBL] [Abstract][Full Text] [Related]
18. The effect of isoproterenol on the class III effect of azimilide in humans.
Dorian P; Dunnmon P; Elstun L; Newman D
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):211-7. PubMed ID: 12490966
[TBL] [Abstract][Full Text] [Related]
19. L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation.
Guo D; Zhao X; Wu Y; Liu T; Kowey PR; Yan GX
J Cardiovasc Electrophysiol; 2007 Feb; 18(2):196-203. PubMed ID: 17212595
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia.
Brooks RR; Carpenter JF; Miller KE; Maynard AE
Proc Soc Exp Biol Med; 1996 May; 212(1):84-93. PubMed ID: 8618956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
